Drug intelligence / Profile preview

gallium (67Ga) citrate

Development stage
Approved
Lead developer
Lantheus
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intravenous
01

Overview

Gallium citrate Ga-67 is a diagnostic radiopharmaceutical agent used in nuclear medicine for Single-Photon Emission Computed Tomography (SPECT) imaging. When administered intravenously, gallium-67 behaves similarly to ferric iron (Fe3+) and binds to plasma proteins, primarily serotransferrin. The resulting gallium-transferrin complex circulates and preferentially accumulates in tissues with high metabolic activity, such as active inflammatory lesions and certain viable primary and metastatic tumors (including Hodgkin's disease, lymphomas, and bronchogenic carcinoma). This cellular uptake is mediated by transferrin receptors, which are highly expressed on rapidly dividing cancer cells and activated leukocytes. Once inside the cells, gallium concentrates in lysosomes and binds to intracellular proteins. The gamma radiation emitted by the decaying gallium-67 isotope is then detected by a gamma camera to produce scintigraphic images, aiding in the localization and evaluation of neoplastic and inflammatory pathologies.

Brand names
GalliumNeoscan
Other names
67Ga-citrateGa-67 citrateGa67 citrateGa 67 citrateGa-67 Gallium CitrateGa67 Gallium CitrateGa 67 Gallium Citrategallium citrate Ga 67gallium citrate Ga-67gallium-67 citrategallium67 citrategallium 67 citrate
02

Targets

TFRC (Transferrin Receptor)

Beyond the preview

Go deeper on gallium (67Ga) citrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium (67Ga) citrate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call